je.st
news
North Shore-LIJ study of blood thinners finds no advantage to much more costly drug
2015-09-06 20:05:54| Biotech - Topix.net
Dr. Peter Berger, senior vice president for clinical research with the North Shore-LIJ Health System, assessed data from a large clinical trial and said Angiomax, a drug that is 400 times more expensive than old-fashioned heparin, may not be worth the cost during placement of a stent to open a clogged artery. Photo Credit: NSLIJ Dr. Peter Berger, senior vice president for clinical research with the North Shore-LIJ Health System, assessed data from a large clinical trial and said Angiomax, a drug that is 400 times more expensive than old-fashioned heparin, may not be worth the cost during placement of a stent to open a clogged artery.
Tags: north
study
advantage
blood
Category:Biotechnology and Pharmaceuticals